Business
JP Morgan initiates coverage of Telix Pharmaceuticals. After rising 1,667% in 5 years, is it still a buy?
Image source: Getty Images
Telix Pharmaceuticals Ltd (ASX: TLX) shares have been a standout performer over the past 5 years.
The ASX 200 radiopharmaceutical company has soared a staggering 1,667% over that timeframe.
Over the past year, shares are up 21%.
Early and recent investors in Telix…
Continue Reading